BACE1 and Alzheimer disease: Fotuhi et al. also found that the level of BACE1-AS lncRNA in plasma-derived EVs significantly differs between AD patients and healthy controls, and that the plasma-derived EV lncRNA BACE1-AS exhibited great diagnostic power for pre-AD (sensitivity, 75%; specificity, 100%) [177].